2,3-butylene glycol has been researched along with Insulin Resistance in 2 studies
2,3-butylene glycol: RN given refers to cpd without isomeric designation
butane-2,3-diol : A butanediol in which hydroxylation is at C-2 and C-3.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, D | 1 |
| Dhillon, AS | 1 |
| Abelmann, A | 1 |
| Croft, K | 1 |
| Peters, TJ | 1 |
| Palmer, TN | 1 |
| Lomeo, F | 1 |
| Khokher, MA | 1 |
| Dandona, P | 1 |
2 other studies available for 2,3-butylene glycol and Insulin Resistance
| Article | Year |
|---|---|
Alcohol-related diols cause acute insulin resistance in vivo.
Topics: Alcoholism; Animals; Blood Glucose; Butylene Glycols; Diabetes Mellitus, Type 2; Glycogen; Insulin; | 1998 |
Ethanol and its novel metabolites inhibit insulin action on adipocytes.
Topics: Acetaldehyde; Adipose Tissue; Animals; Butylene Glycols; Carbon Dioxide; Ethanol; Fatty Acids; Gluco | 1988 |